Search Results  for 'ALNEV.PA'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Neovacs SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

12 Apr 2014 Reuters Investment Profile 12 $20.00

Neovacs SA (ALNEV) - Financial Analysis Review

Neovacs SA (ALNEV) - Financial Analysis Review Summary Neovacs SA (Neovacs) is a pharmaceutical company. The company de...

07 Mar 2014 GlobalData 29 $125.00

NEOVACS - RHEUMATOID ARTHRITIS IS ON TRACK

Neovacs is recruiting for its Phase IIb trial with its TNFα-Kinoid in rheumatoid arthritis (RA). The study is designed to hig...

21 Feb 2014 Edison Investment Research 7 $10.00

Neovacs SA (ALNEV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Neovacs SA (ALNEV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Neovacs SA (Neovacs) is a pharmaceuti...

13 Feb 2014 GlobalData 19 $250.00

Neovacs SA (ALNEV) - Financial Analysis Review

Neovacs SA (ALNEV) - Financial Analysis Review Summary Neovacs SA (Neovacs) is a pharmaceutical company. The company de...

06 Jan 2014 GlobalData 28 $125.00

Neovacs SA (ALNEV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Neovacs SA (ALNEV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Neovacs SA (Neovacs) is an innovative...

13 Dec 2013 GlobalData 19 $250.00

Neovacs SA (ALNEV) - Financial Analysis Review

Neovacs SA (ALNEV) - Financial Analysis Review Summary Neovacs SA (Neovacs) is an innovative biotechnology company. It ...

20 Nov 2013 GlobalData 29 $125.00

Neovacs SA (ALNEV) - Financial Analysis Review

Neovacs SA (ALNEV) - Financial Analysis Review Summary Neovacs SA (Neovacs) is an innovative biotechnology company. It ...

17 Oct 2013 GlobalData 27 $125.00

NEOVACS - RONTA EXIT SPELLS GOOD NEWS FOR NEOVACS

Roche’s decision not to develop rontalizumab, its IFNα monoclonal antibody, any further after completing Phase II trials in s...

17 Oct 2013 Edison Investment Research 7 $10.00

Neovacs SA (ALNEV) - Financial Analysis Review

Neovacs SA (ALNEV) - Financial Analysis Review Summary Neovacs SA (Neovacs) is an innovative biotechnology company. It ...

17 Sep 2013 GlobalData 27 $125.00